Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A stromal-state dichotomy governs recalcitrance or remission in inflammatory bowel disease.

bioRxiv : the preprint server for biology·2026
Same author

An Endocytic Checkpoint Controls Macrophage PD-1 Function and Immunotherapy Fate.

bioRxiv : the preprint server for biology·2026
Same author

A NOD2-Encoded Toggle Switch Resolves the Host-Microbe Battle Over Cyclic AMP Control.

bioRxiv : the preprint server for biology·2026
Same author

Ferroptosis-Driven Anticancer Activity of 1,3,4-Oxadiazole-Benzimidazole/Acetamide Hybrids: Design, Synthesis, and Biological Profiling.

Archiv der Pharmazie·2026
Same author

Integrating Human Intestinal Organoids into FDA's New Approach Methodologies for Drug Discovery.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

A Druggable G Protein Checkpoint in Cholesterol Efflux.

bioRxiv : the preprint server for biology·2026
Same journal

Cancer immunotherapy with oncolytic myxoma virus.

Advances in cancer research·2026
Same journal

Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents.

Advances in cancer research·2026
Same journal

Advancing clinical translation of oncolytic adenoviruses.

Advances in cancer research·2026
Same journal

Operation oncolysis: Reoviruses in the theater of cancer war.

Advances in cancer research·2026
Same journal

AAV vectors for cancer gene therapy.

Advances in cancer research·2026
Same journal

Vesicular stomatitis virus (VSV) as an oncolytic therapeutic agent for cancer.

Advances in cancer research·2026
See all related articles

Related Experiment Video

Updated: Nov 1, 2025

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
06:38

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells

Published on: January 22, 2021

6.4K

Modeling colorectal cancers using multidimensional organoids.

Ibrahim M Sayed1, Amer Ali Abd El-Hafeez2, Priti P Maity2

  • 1Department of Pathology, University of California, San Diego, CA, United States.

Advances in Cancer Research
|June 21, 2021
PubMed
Summary
This summary is machine-generated.

Colon organoids are advanced models for cancer research, drug discovery, and personalized medicine. This review focuses on optimizing these organoids for studying colon health and disease, enabling high-throughput clinical trials.

Keywords:
CRCClinical trialsCocultureColon organoidDrug screeningMultidimensional

More Related Videos

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids
10:23

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids

Published on: May 3, 2024

1.2K
Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
06:49

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Published on: February 10, 2023

2.2K

Related Experiment Videos

Last Updated: Nov 1, 2025

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
06:38

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells

Published on: January 22, 2021

6.4K
Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids
10:23

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids

Published on: May 3, 2024

1.2K
Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
06:49

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Published on: February 10, 2023

2.2K

Area of Science:

  • Biomedical research
  • Cancer biology
  • Organoid technology

Background:

  • Organoids are adaptable models preserving genetic and phenotypic traits of source tissues.
  • They are increasingly used in drug discovery, therapeutic response tracking, and personalized medicine.
  • Organoids are becoming a cornerstone of modern cancer research.

Purpose of the Study:

  • To review the optimization of colon-derived organoids.
  • To establish them as multidimensional, scalable, and reproducible models.
  • To explore their application in high-throughput "Phase-0" human clinical trials-in-a-dish.

Main Methods:

  • Review of current organoid technology and applications.
  • Analysis of methods for perfecting colon organoid models.
  • Discussion of scalability and reproducibility in organoid culture.
  • Exploration of high-throughput screening and "Phase-0" trial integration.

Main Results:

  • Organoids offer a relevant platform for interrogating tissue morphology and function.
  • Colon organoids can accurately model healthy, pre-neoplastic, and neoplastic conditions.
  • Optimized organoids facilitate drug discovery and personalized medicine approaches.
  • Potential for high-throughput screening in pre-clinical drug development.

Conclusions:

  • Colon organoids are pivotal for advancing cancer research and personalized medicine.
  • Further refinement of colon organoids enhances their utility in clinical applications.
  • These models are essential for future "Phase-0" clinical trials, accelerating therapeutic development.